Prof. Dr. med. Markus Maeurer
FB 04 - Universitätsmedizin, Johannes Gutenberg-Universität Mainz
- 06131/39-33645
- 06131/39-35580
Mazzocchi, Arabella; Storkus, Walter J.; Traversari, Catia et al.
Multiple Melanoma-Associated Epitopes Recognized by HLA-A3-Restricted CTLs and Shared by Melanomas but Not MelanocytesThe journal of immunology. official journal of the American Association of Immunologists. Bd. 157. H. 7. Bethesda, Md.: American Assoc. of Immunologists 1996 S. 3030 - 3038
Maeurer, M.; Storkus, W.; Kirkwood, J. et al.
New treatment options for patients with melanoma: review of melanoma - derived T-cell epitope-based peptide vaccinesMelanoma Res. Bd. Melanoma Res. 1996 S. 11-24
Bernhard, H.; Maeurer, M.J.; Jäger, E. et al.
Recognition of Human Renal Cell Carcinoma and Melanoma by HLA-A2-Restricted Cytotoxic T Lymphocytes is Mediated by Shared Peptide Epitopes and Up-Regulated by Interferon-gScandinavian journal of immunology. the official journal of the Scandinavian Society for Immunology. Bd. 44. H. 3. Oxford [u.a.]: Blackwell 1996 S. 285 - 292
Bernhard, H.; Jäger, E.; Maeurer, M.J. et al.
Tumor associated antigens in human renal cell carcinoma: MHC restricted recognition by cytotoxic T lymphocytesTissue antigens. histocompatibility and immunogenetics. Bd. 48. H. 1. Oxford: Blackwell Munksgaard 1996 S. 22 - 31
Maeurer, Markus J.; Gollin, Susanne M.; Storkus, Walter J. et al.
Tumor Escape from Immune Recognition: Loss of HLA-A2 Melanoma Cell Surface Expression Is Associated with a Complex Rearrangement of the Short Arm of Chromosome 6Clinical cancer research. an official journal of the American Association for Cancer Research. Bd. 2. H. 4. Philadelphia, Pa. [u.a.]: AACR 1996 S. 641 - 652
Maeurer, M.J.; Gollin, S.M.; Martin, D. et al.
Tumor escape from immune recognition. Lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1-Melan-A antigenThe journal of clinical investigation. JCI ; the publication of the American Society for Clinical Investigation. Bd. 98. H. 7. Ann Arbor, Mich.: American Society for Clinical Investigation 1996 S. 1633 - 1641
Maeurer, M.; Hurd, S.; Martin, D. et al.
Cytolytic T-cell clones define HLA-A2 restricted human cutaneous melanoma peptide epitopes - correlation with T-cell receptor usageCancer J. Sci. Am. Bd. Cancer J. Sci. Am. 1995 S. 162-170
Maeurer, Markus; Maeurer, M. J.; Martin, D. M. et al.
Evidence for shared TCR usage in CTL recognizing HLA-A2 presented antigens shared by melanoma and melanocytesImmunology Today. Bd. Immunology Today. 1995 S. 603-604
Maeurer, M.J.; Martin, D.M.; Castelli, C. et al.
Host immune response in renal cell cancer: Interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytesCancer immunology immunotherapy. CII ; other biological response modification. Bd. 41. H. 2. Berlin: Springer 1995 S. 111 - 121
Castelli, Chiara; Storkus, Walter J.; Maeurer, Markus J. et al.
Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytesThe journal of experimental medicine. JEM. Bd. 181. H. 1. New York, NY: Rockefeller Univ. Press 1995 S. 363 - 368